Prinston Laboratories is a generic pharmaceutical company that focuses on the development, manufacturing, and marketing of both sterile and non-sterile dosage forms, including injectables and topicals. The company emphasizes its expertise in producing difficult-to-make generic products, which is supported by a robust Research and Development (R&D) team. With facilities located in Somerset, NJ, and Shanghai, China, Prinston is dedicated to maintaining a continuous pipeline of new products, with over 75 products currently under development or filed with regulatory agencies in the United States. This commitment to innovation allows Prinston to offer more affordable pharmaceutical options to patients.

In addition to its R&D capabilities, Prinston Laboratories operates manufacturing facilities in Zhejiang Linhai, China, and Charlotte, NC. The company prioritizes advancements in science and technology to enhance the quality and reliability of its generic products. By focusing on proactive cost reductions and supply reliability, Prinston aims to remain a leading partner in the generic pharmaceutical industry. The company's strategic approach to R&D and manufacturing positions it to adapt to the evolving pharmaceutical market and meet the growing demand for affordable medicines.

United States

We are a fully integrated pharmaceutical company located in Cranbury, engaged in developing and sales & marketing of generic pharmaceutical products in North American and South American markets. Since launching our first product, Benazepril in 2010, we have launched 11 products in U.S. market. Through reliable products’ quality, manufacturing capability and competitively strategic API resources from China, we have successfully reduced the medical cost for American buyers and help millions of patients against their illness.

Prinston Laboratories

Company Details